Literature DB >> 3066641

Nocturnal asthma: snoring, small pharynx and nasal CPAP.

C Guilleminault1, M A Quera-Salva, N Powell, R Riley, A Romaker, M Partinen, R Baldwin, G Nino-Murcia.   

Abstract

We studied two populations of patients who snored and had frequent nocturnal asthma attacks: ten overweight men presenting with typical obstructive sleep apnoea syndrome, and a group of five adolescents with regular snoring and an increase in negative inspiratory oesophageal pressure during stage II non-rapid eye movement (NREM) and rapid eye movement (REM) sleep. All subjects presented cranio-mandibular abnormalities at cephalometric evaluation, with a narrow space behind the base of the tongue. Both populations were treated with nasal continuous positive airway pressure (CPAP) during sleep. Snoring and partial or complete airway obstruction were eliminated, as were the nocturnal asthma attacks. Two adolescents treated with upper airway surgery after nasal CPAP showed no nocturnal asthma at short-term follow-up. Nasal CPAP had no effect on daytime asthma. One hypothesis is that a subgroup of asthmatic patients with small pharynxes may have enhanced vagal stimulation during sleep compared with other asthmatic patients. This enhancement would be related to the repetitive Müller manoeuvres noted with airway obstruction during sleep. Combined with the local effects of snoring, this extra vagal stimulation would be a precipitating factor in nocturnal asthma attacks.

Entities:  

Mesh:

Year:  1988        PMID: 3066641

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  24 in total

1.  Habitual snoring and asthma comorbidity among pregnant women.

Authors:  Michelle A Williams; Bizu Gelaye; Chunfang Qiu; Neway Fida; Swee May Cripe
Journal:  J Asthma       Date:  2010-11-24       Impact factor: 2.515

2.  Long-term CPAP treatment improves asthma control in patients with asthma and obstructive sleep apnoea.

Authors:  Paula Kauppi; Patrick Bachour; Paula Maasilta; Adel Bachour
Journal:  Sleep Breath       Date:  2016-04-07       Impact factor: 2.816

3.  Obstructive Sleep Apnea Risk, Asthma Burden, and Lower Airway Inflammation in Adults in the Severe Asthma Research Program (SARP) II.

Authors:  Mihaela Teodorescu; Oleg Broytman; Douglas Curran-Everett; Ronald L Sorkness; Gina Crisafi; Eugene R Bleecker; Serpil Erzurum; Benjamin M Gaston; Sally E Wenzel; Nizar N Jarjour
Journal:  J Allergy Clin Immunol Pract       Date:  2015-05-21

4.  Effect of asthma on the risk of obstructive sleep apnea syndrome in atopic women.

Authors:  Maninder Kalra; Jocelyn Biagini; David Bernstein; Sherry Stanforth; Jeffrey Burkle; Aliza Cohen; Grace LeMasters
Journal:  Ann Allergy Asthma Immunol       Date:  2006-08       Impact factor: 6.347

5.  Association of obstructive sleep apnea risk or diagnosis with daytime asthma in adults.

Authors:  Mihaela Teodorescu; David A Polomis; Mihai C Teodorescu; Ronald E Gangnon; Andrea G Peterson; Flavia B Consens; Ronald D Chervin; Nizar N Jarjour
Journal:  J Asthma       Date:  2012-06-28       Impact factor: 2.515

Review 6.  Asthma and Obstructive Sleep Apnea Overlap: What Has the Evidence Taught Us?

Authors:  Bharati Prasad; Sharmilee M Nyenhuis; Ikuyo Imayama; Aminaa Siddiqi; Mihaela Teodorescu
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

7.  Nocturnal asthma.

Authors:  N J Douglas
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

8.  Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases.

Authors:  Matteo Ferrando; Diego Bagnasco; Valeria Roustan; Giorgio Walter Canonica; Fulvio Braido; Ilaria Baiardini
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 9.  Obesity in asthma: approaches to treatment.

Authors:  Shyamala Pradeepan; Garth Garrison; Anne E Dixon
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

10.  Obstructive sleep apnea syndrome and bronchial hyperreactivity.

Authors:  C C Lin; C Y Lin
Journal:  Lung       Date:  1995       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.